Interleukin-6 Signaling Blockade Induces Regulatory Plasmablasts in Neuromyelitis Optica Spectrum Disorder.
Ritsu AkataniNorio ChiharaAtsushi HaraAsato TsujiShusuke KotoKazuhiro KobayashiTatsushi TodaRiki MatsumotoPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
PBs may be a marker of treatment responsiveness in the context of NMOSD pathophysiology.
Keyphrases